OTR acting director
Executive Summary
FDA Office of Testing & Research Division of Pharmaceutical Analysis Director Cindy Buhse succeeds Ajaz Hussain as OTR acting director effective Oct. 31. Buhse has worked at the agency since 2001. Hussain, who also served as deputy director of the Office of Pharmaceutical Science, left FDA Oct. 28 to become VP-biopharmaceutical development at Sandoz (1"The Pink Sheet" Oct. 10, 2005, p. 3)...
You may also be interested in...
New OTR director
FDA appoints Vincent Vilker as director of the Office of Testing and Research, within the Office of Pharmaceutical Science. Vilker replaces Ajaz Hussain, who left FDA in October to become VP-biopharmaceutical development at Sandoz (1"The Pink Sheet" Oct. 31, 2005, In Brief). Vilker hails from the National Institute of Standards where he served as chief of the biotechnology division...
FDA Implementing New CMC Review Process Through Revamped Office
FDA is changing its review of chemistry, manufacturing and controls submissions with a new quality assessment office that will involve greater staff specialization
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.